Elsevier

Vaccine

Volume 25, Issue 22, 30 May 2007, Pages 4340-4344
Vaccine

Short communication
Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines

https://doi.org/10.1016/j.vaccine.2007.03.027Get rights and content

Abstract

Targeting dendritic cell mannose receptors by mannosylating antigens represents a promising vaccination strategy. Using the model antigen ovalbumin (OVA) expressed recombinantly in bacterial and yeast vectors, we have previously demonstrated fungal mannosylation enhances antigen immunogenicity in the context of CD4+ T cell responses. However, because protection against many tumors and pathogens is thought to require MHC class I-restricted T cell responses, the capacity of differentially mannosylated OVA antigens to induce antigen-specific CD8+ T cell proliferation was determined. We found that mannosylated yeast-derived OVA antigens were more potent than their unmannosylated counterparts at inducing antigen-specific T cell proliferation. However, the type of mannosylation was critical as addition of extensive O-linked mannosylation increased lymphoproliferative responses while the presence of N-linked mannosylation was associated with decreased responses. Mannosylated OVA failed to stimulate TNF-α and IL-12 production from dendritic cells. These data suggest that vaccines incorporating mannosylation must take into account how the mannose groups are linked to the core antigen and may need to include an adjuvant to stimulate cytokine production.

Introduction

Numerous vaccines which protect by inducing antibody responses are currently licensed for use in humans [1], [2]. However, for some pathogens (e.g., human immunodeficiency virus and Mycobacterium tuberculosis) and tumors, antibody responses are thought to be insufficient for complete protection [3]. By comparison, few vaccines are available which protect by inducing T cell-mediated immune responses [4]. In an effort to develop vaccines which induce cell-mediated immune responses, antigen mannosylation represents a promising strategy for enhancing antigen immunogenicity by targeting mannose receptors (MRs) on antigen-presenting cells (APCs) [5]. Mannosylation of antigens can be accomplished by chemical conjugation or by exploiting the natural capacity of fungi to preferentially use mannose groups when adding O- and N-linkages [6]. Using the model antigen OVA expressed in the yeast Pichia pastoris, we have demonstrated that fungal mannosylation enhances antigen immunogenicity in the context of major histocompatibility complex (MHC) class II-restricted CD4+ T cell responses [7]. Moreover, the presence of either O-linked or N-linked mannosylation was sufficient to boost antigen-specific CD4+ T cell stimulation. Optimal protection against many tumors and pathogens is thought to require the induction of MHC class I-restricted CD8+ T cell responses [8], [9]. Recognizing the value of priming cytotoxic T lymphocyte responses, Stubbs et al. have shown that vaccination of mice with yeast engineered to express tumor antigens induced protective antigen-specific CD8+ T cell responses [10].

The purpose of this study was to evaluate the capacity of fungal mannosylation to: (1) enhance antigen immunogenicity in the context of MHC class I-restricted CD8+ T cell responses and, (2) stimulate DC proinflammatory cytokine production. Unmannosylated OVA antigens were produced in Escherichia coli; whereas mannosylated OVA antigens were produced in the yeast P. pastoris. To examine the relative contributions of the type of mannosylation, the degree of N- and O-linkages was manipulated by site-directed mutagenesis of the asparagine-X-serine/threonine sequences responsible for N-linkages and the addition of a serine/threonine-rich region to provide extensive O-linkages. We found that mannosylated OVA antigens were significantly more potent than their unmannosylated counterparts at inducing antigen-specific CD8+ lymphoproliferation. Additionally, N-linked mannosylation decreased the immunogenicity of OVA antigens, whereas extensive O-linked mannosylation was stimulatory. Surprisingly, despite their less potent capacity to stimulate antigen-specific lymphoproliferation, unmannosylated antigens stimulated higher levels of tumor necrosis factor alpha (TNF-α) and interleukin 12 (IL-12) p70 production than mannosylated antigens.

Section snippets

Materials and cell culture

All chemical reagents were purchased from Sigma–Aldrich (St. Louis, MO) unless otherwise noted. Native OVA was purchased from Worthington Biochemical Corporation (Lakewood, NJ). Heat-killed, formalin-fixed Staphylococcus aureus Cowan 1 (SAC) bacterial cells were purchased from Calbiochem (La Jolla, CA). Tissue culture media were obtained from Invitrogen Life Technologies. R10 medium consisted of RPMI 1640 supplemented with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM l-glutamine and

Effect of antigen mannosylation on OT-I lymphoproliferation

To determine the relative potency of unmannosylated versus mannosylated antigens at inducing antigen-specific T cell proliferation, BMDCs were cocultured with naïve OVA-specific CD8+ T cells in the presence of recombinant OVA antigens. BSA and native OVA served as negative and positive controls, respectively. Mannosylated ppOVA and ppOVAST were significantly more potent at inducing OT-I lymphoproliferation than unmannosylated ecOVA and ecOVAST (Fig. 1A). Because ppOVA and ppOVAST were

Discussion

We evaluated the capacity of fungal mannosylation to enhance antigen immunogenicity in the context of MHC class I-restricted CD8+ T cell responses. Unmannosylated and differentially mannosylated OVA antigens were used to stimulate antigen-specific T cell proliferation. Our results demonstrated a three-fold enhancement of OVA-specific CD8+ T cell proliferation induced by mannosylated ppOVA and ppOVAST versus unmannosylated ecOVA and ecOVAST, respectively (Fig. 1A). These data extend our previous

Acknowledgements

This work was supported in part by National Institutes of Health grants RO1 AI066087 and RO1 AI25780. We thank Jennifer Dan and Dr. Karen Wozniak for help with experimental design and interpretation.

References (27)

  • M.T. Esser et al.

    Memory T cells and vaccines

    Vaccine

    (2003)
  • M.B. Lutz et al.

    An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

    J Immunol Methods

    (1999)
  • T. Ben-Yedidia et al.

    Towards an epitope-based human vaccine for influenza

    Hum Vaccine

    (2005)
  • S. Ljubojevic

    The human papillomavirus vaccines

    Acta Dermatovenerol Croat

    (2006)
  • I.K. Srivastava et al.

    Neutralizing antibody responses to HIV: role in protective immunity and challenges for vaccine design

    Expert Rev Vaccines

    (2004)
  • T. Keler et al.

    Mannose receptor-targeted vaccines

    Expert Opin Biol Ther

    (2004)
  • S.M. Levitz et al.

    The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins

    FEMS Yeast Res

    (2006)
  • J.S. Lam et al.

    A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity

    J Immunol

    (2005)
  • J.T. Harty et al.

    CD8+ T cell effector mechanisms in resistance to infection

    Annu Rev Immunol

    (2000)
  • C.A. Klebanoff et al.

    Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

    Proc Natl Acad Sci U S A

    (2005)
  • A.C. Stubbs et al.

    Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity

    Nat Med

    (2001)
  • S.M. Levitz et al.

    Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans

    Proc Natl Acad Sci U S A

    (2001)
  • P. Lundberg et al.

    TNF protects resistant C57BL/6 mice against herpes simplex virus induced encephalitis independently of signaling via TNFR1 or TNFR2

    J Virol

    (2006)
  • Cited by (48)

    • Exceptionally long CDR3H of bovine scFv antigenized with BoHV-1 B-epitope generates specific immune response against the targeted epitope

      2016, Molecular Immunology
      Citation Excerpt :

      Expression of these recombinant proteins in P. pastoris for immunization may be advantageous as the addition of O-linked mannose residues may contribute to enhanced antigenicity without significantly affecting the configuration of the newly identified B epitope of the gC viral envelope protein. Indeed, mannose rich glycoproteins are known to target mannose receptors on dendritic cells that may enhance antigen-specific CD4+ T-cell responses more potently than non-mannosylated proteins (Luong et al., 2007). Both gC156 and gC156scFv1H12 induced a specific immune response in the natural bovine host and the elicited antibodies cross-recognized both the free gC156 fragment and the Ag-scFv.

    • Vaccine immunity against fungal infections

      2014, Current Opinion in Immunology
      Citation Excerpt :

      Candidate vaccines comprising Glucoronoxylomannan (GXM), peptide mimotopes of GXM, cell filtrate antigens (Cnef) and protein-conjugated laminaran were shown to mediate protection by inducing antibodies and promoting Th1 cell responses (Table 1). Mannosylation of protein antigen has been shown to greatly promote anti-cryptococcal Th1 and CD8+ T cell responses and protective immunity [13]. Pneumocystis pneumonia is generally restricted to immunocompromised patients and carries a high mortality rate.

    • Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris

      2012, Journal of Immunological Methods
      Citation Excerpt :

      Furthermore, Mansour and co-workers showed that β-elimination of O-mannose decreases T cell responses mediated by fungal mannoprotein by about 90%, whereas removal of N-glycans by PNGaseF or EndoH digestion did not affect immunoreactivity (Mansour et al., 2006). Additionally, another study showed that MHC Class I-restricted ovalbumin antigens with N-linked high-mannose-type glycans inhibit CD8 + T lymphocyte activation whereas extensive O-linked mannosylation was stimulatory (Luong et al., 2007). DCs can present extracellular antigens via MHC Class I in a process known as cross-presentation (Rodriguez et al., 1999).

    • Influence of protein expression system on elicitation of IgE antibody responses: Experience with lactoferrin

      2012, Toxicology
      Citation Excerpt :

      There is a more substantial literature supporting the impact of these sugar residues on immunogenicity (IgG antibody and T cell responses). Production of recombinant mannosylated ovalbumin (a model antigen and allergen) in yeast revealed enhanced immunogenicity with respect to CD4 and CD8 T cell proliferative responses, although antibody responses were not measured (Luong et al., 2007). Furthermore, the nature of the mannosylation was critical, with O-linked mannose residues (linked through serine/threonine) associated with increased lymphoproliferative responses whereas N-linked mannosylation resulted in decreased responses.

    View all citing articles on Scopus
    View full text